143 related articles for article (PubMed ID: 37967960)
21. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
[TBL] [Abstract][Full Text] [Related]
22. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
[TBL] [Abstract][Full Text] [Related]
23. [ENHANCED CLINICAL EFFECTS OF CEDARCURE
Yuta A; Ogawa Y; Murao T; Kozaki H; Shimizu T
Arerugi; 2022; 71(9):1122-1128. PubMed ID: 36372423
[TBL] [Abstract][Full Text] [Related]
24. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis.
Kurokawa T; Yonekura S; Gotoh M; Okano M; Maekawa Y; Okubo K; Okamoto Y
J Allergy Clin Immunol Glob; 2023 May; 2(2):100075. PubMed ID: 37780797
[TBL] [Abstract][Full Text] [Related]
26. [Increased throat symptoms in Japanese cypress pollinosis].
Ogihara H; Yuta A; Miyamoto Y; Kitano M; Takeo T; Takeuchi K
Nihon Jibiinkoka Gakkai Kaiho; 2011 Feb; 114(2):78-83. PubMed ID: 21409844
[TBL] [Abstract][Full Text] [Related]
27. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
28. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
Yonekura S; Gotoh M; Kaneko S; Maekawa Y; Okubo K; Okamoto Y
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
[TBL] [Abstract][Full Text] [Related]
29. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
[TBL] [Abstract][Full Text] [Related]
30. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
[TBL] [Abstract][Full Text] [Related]
31. The Relationship of Pollen Dispersal with Allergy Symptoms and Immunotherapy: Allergen Immunotherapy Improves Symptoms in the Late Period of Japanese Cedar Pollen Dispersal.
Sakurai T; Yonekura S; Iinuma T; Sakurai D; Morimoto Y; Kaneko S; Okamoto Y
Int Arch Allergy Immunol; 2018; 177(3):245-254. PubMed ID: 30021201
[TBL] [Abstract][Full Text] [Related]
32. Cedar and cypress pollen counts are associated with the prevalence of allergic diseases in Japanese schoolchildren.
Yoshida K; Adachi Y; Akashi M; Itazawa T; Murakami Y; Odajima H; Ohya Y; Akasawa A
Allergy; 2013 Jun; 68(6):757-63. PubMed ID: 23621581
[TBL] [Abstract][Full Text] [Related]
33. [Adverse Events of Sublingual Immunotherapy in 207 Patients with Japanese Cedar Pollinosis].
Ogawa Y; Yuta A; Arikata M; Kozaki H; Ohta N; Suzuki Y; Shimizu T
Nihon Jibiinkoka Gakkai Kaiho; 2015 Dec; 118(12):1429-35. PubMed ID: 26964395
[TBL] [Abstract][Full Text] [Related]
34. The Combined Effects of Sublingual Immunotherapy and Lactobacillus acidophilus-Producing Extract on Cedar Pollinosis Symptoms.
Hirobumi I; Sasuga Y
Cureus; 2023 Jul; 15(7):e41374. PubMed ID: 37408939
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of sublingual immunotherapy for cedar pollinosis: A systematic review and meta-analysis.
Yang Y; Zhou W; Chen A
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):348-353. PubMed ID: 27566862
[TBL] [Abstract][Full Text] [Related]
36. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
[No Abstract] [Full Text] [Related]
37. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
38. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
[TBL] [Abstract][Full Text] [Related]
39. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE SECOND TREATED YEAR FOR 133 PATIENTS WITH JAPANESE CEDAR POLLINOSIS IN 2016].
Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
Arerugi; 2016; 65(9):1209-1218. PubMed ID: 27885205
[TBL] [Abstract][Full Text] [Related]
40. [EFFICACY AND SAFETY OF PEDIATRIC SUBLINGUAL IMMMUNOTHERAPY WITH CEDARCURE
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Shimizu T
Arerugi; 2020; 69(9):909-917. PubMed ID: 33191379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
